nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP3A4—type 2 diabetes mellitus	0.174	1	CbGaD
Raloxifene—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0835	0.163	CbGbCtD
Raloxifene—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0746	0.146	CbGbCtD
Raloxifene—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.046	0.0899	CbGbCtD
Raloxifene—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0367	0.0719	CbGbCtD
Raloxifene—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0332	0.065	CbGbCtD
Raloxifene—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0307	0.06	CbGbCtD
Raloxifene—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0296	0.0579	CbGbCtD
Raloxifene—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0241	0.0472	CbGbCtD
Raloxifene—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0209	0.0409	CbGbCtD
Raloxifene—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0186	0.0365	CbGbCtD
Raloxifene—CYP3A4—Glipizide—type 2 diabetes mellitus	0.017	0.0333	CbGbCtD
Raloxifene—CYP2C8—Losartan—type 2 diabetes mellitus	0.0156	0.0304	CbGbCtD
Raloxifene—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0149	0.0291	CbGbCtD
Raloxifene—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0135	0.0264	CbGbCtD
Raloxifene—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0102	0.02	CbGbCtD
Raloxifene—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00979	0.0192	CbGbCtD
Raloxifene—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00979	0.0192	CbGbCtD
Raloxifene—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00926	0.0181	CbGbCtD
Raloxifene—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0069	0.0135	CbGbCtD
Raloxifene—CYP3A4—Losartan—type 2 diabetes mellitus	0.00631	0.0123	CbGbCtD
Raloxifene—EBP—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00175	1	CbGdCrCtD
Raloxifene—EBP—liver—type 2 diabetes mellitus	0.000823	0.0718	CbGeAlD
Raloxifene—AOX1—islet of Langerhans—type 2 diabetes mellitus	0.000616	0.0538	CbGeAlD
Raloxifene—AOX1—nephron tubule—type 2 diabetes mellitus	0.000496	0.0433	CbGeAlD
Raloxifene—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.000496	0.0433	CbGeAlD
Raloxifene—ESR2—cardiovascular system—type 2 diabetes mellitus	0.000463	0.0404	CbGeAlD
Raloxifene—ESR2—kidney—type 2 diabetes mellitus	0.000453	0.0395	CbGeAlD
Raloxifene—AOX1—kidney—type 2 diabetes mellitus	0.000436	0.0381	CbGeAlD
Raloxifene—AOX1—pancreas—type 2 diabetes mellitus	0.000433	0.0378	CbGeAlD
Raloxifene—AOX1—cortex of kidney—type 2 diabetes mellitus	0.000425	0.0371	CbGeAlD
Raloxifene—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.0004	0.0349	CbGeAlD
Raloxifene—AOX1—adipose tissue—type 2 diabetes mellitus	0.000393	0.0343	CbGeAlD
Raloxifene—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000358	0.0312	CbGeAlD
Raloxifene—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000349	0.0304	CbGeAlD
Raloxifene—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000342	0.0298	CbGeAlD
Raloxifene—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000341	0.0298	CbGeAlD
Raloxifene—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000322	0.0281	CbGeAlD
Raloxifene—ESR1—cardiovascular system—type 2 diabetes mellitus	0.000317	0.0277	CbGeAlD
Raloxifene—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000316	0.0276	CbGeAlD
Raloxifene—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000316	0.0276	CbGeAlD
Raloxifene—ESR1—kidney—type 2 diabetes mellitus	0.00031	0.0271	CbGeAlD
Raloxifene—ESR2—liver—type 2 diabetes mellitus	0.000286	0.025	CbGeAlD
Raloxifene—ESR1—adipose tissue—type 2 diabetes mellitus	0.00028	0.0244	CbGeAlD
Raloxifene—AOX1—liver—type 2 diabetes mellitus	0.000276	0.0241	CbGeAlD
Raloxifene—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000261	0.0228	CbGeAlD
Raloxifene—CYP2C8—kidney—type 2 diabetes mellitus	0.000256	0.0223	CbGeAlD
Raloxifene—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000234	0.0205	CbGeAlD
Raloxifene—CYP2B6—kidney—type 2 diabetes mellitus	0.000229	0.02	CbGeAlD
Raloxifene—CYP19A1—liver—type 2 diabetes mellitus	0.000226	0.0197	CbGeAlD
Raloxifene—SIGMAR1—liver—type 2 diabetes mellitus	0.000222	0.0194	CbGeAlD
Raloxifene—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000214	0.0011	CcSEcCtD
Raloxifene—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000214	0.0011	CcSEcCtD
Raloxifene—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000214	0.0011	CcSEcCtD
Raloxifene—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000214	0.0011	CcSEcCtD
Raloxifene—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Raloxifene—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Raloxifene—Nausea—Repaglinide—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Raloxifene—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000213	0.0011	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000212	0.0011	CcSEcCtD
Raloxifene—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000212	0.0011	CcSEcCtD
Raloxifene—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000211	0.00109	CcSEcCtD
Raloxifene—Flushing—Irbesartan—type 2 diabetes mellitus	0.000211	0.00109	CcSEcCtD
Raloxifene—Weight increased—Ramipril—type 2 diabetes mellitus	0.000209	0.00108	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000208	0.00107	CcSEcCtD
Raloxifene—Vertigo—Valsartan—type 2 diabetes mellitus	0.000207	0.00107	CcSEcCtD
Raloxifene—Flatulence—Metformin—type 2 diabetes mellitus	0.000207	0.00107	CcSEcCtD
Raloxifene—Syncope—Valsartan—type 2 diabetes mellitus	0.000207	0.00107	CcSEcCtD
Raloxifene—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000207	0.00107	CcSEcCtD
Raloxifene—Vertigo—Orlistat—type 2 diabetes mellitus	0.000205	0.00106	CcSEcCtD
Raloxifene—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000204	0.00105	CcSEcCtD
Raloxifene—Infection—Gliclazide—type 2 diabetes mellitus	0.000204	0.00105	CcSEcCtD
Raloxifene—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000203	0.00105	CcSEcCtD
Raloxifene—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000203	0.00105	CcSEcCtD
Raloxifene—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000202	0.00104	CcSEcCtD
Raloxifene—Cough—Valsartan—type 2 diabetes mellitus	0.000201	0.00104	CcSEcCtD
Raloxifene—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000201	0.00104	CcSEcCtD
Raloxifene—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000201	0.00104	CcSEcCtD
Raloxifene—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000201	0.00104	CcSEcCtD
Raloxifene—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000201	0.00104	CcSEcCtD
Raloxifene—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Raloxifene—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Raloxifene—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Raloxifene—Cough—Orlistat—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Raloxifene—Flushing—Losartan—type 2 diabetes mellitus	0.000199	0.00103	CcSEcCtD
Raloxifene—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000198	0.00102	CcSEcCtD
Raloxifene—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000197	0.00102	CcSEcCtD
Raloxifene—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000197	0.00102	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000197	0.00102	CcSEcCtD
Raloxifene—Chest pain—Valsartan—type 2 diabetes mellitus	0.000196	0.00101	CcSEcCtD
Raloxifene—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000196	0.00101	CcSEcCtD
Raloxifene—Myalgia—Valsartan—type 2 diabetes mellitus	0.000196	0.00101	CcSEcCtD
Raloxifene—Sweating—Ramipril—type 2 diabetes mellitus	0.000196	0.00101	CcSEcCtD
Raloxifene—ESR1—liver—type 2 diabetes mellitus	0.000196	0.0171	CbGeAlD
Raloxifene—Dizziness—Glipizide—type 2 diabetes mellitus	0.000196	0.00101	CcSEcCtD
Raloxifene—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000195	0.00101	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000195	0.00101	CcSEcCtD
Raloxifene—Angiopathy—Losartan—type 2 diabetes mellitus	0.000194	0.001	CcSEcCtD
Raloxifene—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000194	0.001	CcSEcCtD
Raloxifene—Myalgia—Orlistat—type 2 diabetes mellitus	0.000194	0.001	CcSEcCtD
Raloxifene—Chest pain—Orlistat—type 2 diabetes mellitus	0.000194	0.001	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000193	0.000996	CcSEcCtD
Raloxifene—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000192	0.000992	CcSEcCtD
Raloxifene—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000191	0.000985	CcSEcCtD
Raloxifene—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000189	0.000978	CcSEcCtD
Raloxifene—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000189	0.000975	CcSEcCtD
Raloxifene—Vomiting—Glipizide—type 2 diabetes mellitus	0.000189	0.000974	CcSEcCtD
Raloxifene—Syncope—Metformin—type 2 diabetes mellitus	0.000188	0.000973	CcSEcCtD
Raloxifene—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000188	0.00097	CcSEcCtD
Raloxifene—Infection—Valsartan—type 2 diabetes mellitus	0.000187	0.000966	CcSEcCtD
Raloxifene—Rash—Glipizide—type 2 diabetes mellitus	0.000187	0.000966	CcSEcCtD
Raloxifene—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000187	0.000965	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000187	0.000964	CcSEcCtD
Raloxifene—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000187	0.000964	CcSEcCtD
Raloxifene—Headache—Glipizide—type 2 diabetes mellitus	0.000186	0.00096	CcSEcCtD
Raloxifene—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000185	0.000957	CcSEcCtD
Raloxifene—Shock—Valsartan—type 2 diabetes mellitus	0.000185	0.000957	CcSEcCtD
Raloxifene—Infection—Orlistat—type 2 diabetes mellitus	0.000185	0.000955	CcSEcCtD
Raloxifene—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000185	0.000954	CcSEcCtD
Raloxifene—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000185	0.000954	CcSEcCtD
Raloxifene—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000184	0.000952	CcSEcCtD
Raloxifene—Flatulence—Losartan—type 2 diabetes mellitus	0.000184	0.00095	CcSEcCtD
Raloxifene—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000183	0.000945	CcSEcCtD
Raloxifene—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000183	0.000945	CcSEcCtD
Raloxifene—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000182	0.000942	CcSEcCtD
Raloxifene—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000182	0.000942	CcSEcCtD
Raloxifene—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000181	0.000935	CcSEcCtD
Raloxifene—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000181	0.000933	CcSEcCtD
Raloxifene—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000181	0.000933	CcSEcCtD
Raloxifene—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00018	0.000932	CcSEcCtD
Raloxifene—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00018	0.000932	CcSEcCtD
Raloxifene—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00018	0.000929	CcSEcCtD
Raloxifene—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000179	0.000927	CcSEcCtD
Raloxifene—Chest pain—Metformin—type 2 diabetes mellitus	0.000179	0.000924	CcSEcCtD
Raloxifene—Myalgia—Metformin—type 2 diabetes mellitus	0.000179	0.000924	CcSEcCtD
Raloxifene—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000178	0.00092	CcSEcCtD
Raloxifene—Headache—Pioglitazone—type 2 diabetes mellitus	0.000178	0.000919	CcSEcCtD
Raloxifene—Syncope—Irbesartan—type 2 diabetes mellitus	0.000178	0.000918	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000178	0.000917	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000177	0.000914	CcSEcCtD
Raloxifene—Nausea—Glipizide—type 2 diabetes mellitus	0.000176	0.00091	CcSEcCtD
Raloxifene—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000176	0.000909	CcSEcCtD
Raloxifene—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000175	0.000906	CcSEcCtD
Raloxifene—Pain—Gliclazide—type 2 diabetes mellitus	0.000175	0.000905	CcSEcCtD
Raloxifene—Rash—Glimepiride—type 2 diabetes mellitus	0.000174	0.000901	CcSEcCtD
Raloxifene—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000174	0.0009	CcSEcCtD
Raloxifene—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000174	0.0009	CcSEcCtD
Raloxifene—Rash—Sitagliptin—type 2 diabetes mellitus	0.000174	0.000898	CcSEcCtD
Raloxifene—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000174	0.000898	CcSEcCtD
Raloxifene—Headache—Glimepiride—type 2 diabetes mellitus	0.000173	0.000895	CcSEcCtD
Raloxifene—CYP3A4—kidney—type 2 diabetes mellitus	0.000173	0.0151	CbGeAlD
Raloxifene—Cough—Irbesartan—type 2 diabetes mellitus	0.000173	0.000894	CcSEcCtD
Raloxifene—Headache—Sitagliptin—type 2 diabetes mellitus	0.000173	0.000893	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000171	0.000886	CcSEcCtD
Raloxifene—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000171	0.000882	CcSEcCtD
Raloxifene—Flushing—Ramipril—type 2 diabetes mellitus	0.000171	0.000881	CcSEcCtD
Raloxifene—Infection—Metformin—type 2 diabetes mellitus	0.00017	0.00088	CcSEcCtD
Raloxifene—Insomnia—Valsartan—type 2 diabetes mellitus	0.00017	0.00088	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000169	0.000876	CcSEcCtD
Raloxifene—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000169	0.000872	CcSEcCtD
Raloxifene—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000169	0.000872	CcSEcCtD
Raloxifene—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000169	0.000872	CcSEcCtD
Raloxifene—Shock—Metformin—type 2 diabetes mellitus	0.000169	0.000871	CcSEcCtD
Raloxifene—Insomnia—Orlistat—type 2 diabetes mellitus	0.000168	0.000869	CcSEcCtD
Raloxifene—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000168	0.000869	CcSEcCtD
Raloxifene—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000168	0.000867	CcSEcCtD
Raloxifene—Vertigo—Losartan—type 2 diabetes mellitus	0.000168	0.000866	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000168	0.000866	CcSEcCtD
Raloxifene—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000168	0.000866	CcSEcCtD
Raloxifene—Syncope—Losartan—type 2 diabetes mellitus	0.000167	0.000864	CcSEcCtD
Raloxifene—Skin disorder—Metformin—type 2 diabetes mellitus	0.000167	0.00086	CcSEcCtD
Raloxifene—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000166	0.000856	CcSEcCtD
Raloxifene—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000166	0.000856	CcSEcCtD
Raloxifene—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000165	0.000853	CcSEcCtD
Raloxifene—Nausea—Glimepiride—type 2 diabetes mellitus	0.000164	0.000849	CcSEcCtD
Raloxifene—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000164	0.000847	CcSEcCtD
Raloxifene—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000164	0.000846	CcSEcCtD
Raloxifene—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000164	0.000846	CcSEcCtD
Raloxifene—Cough—Losartan—type 2 diabetes mellitus	0.000163	0.000841	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000163	0.00084	CcSEcCtD
Raloxifene—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000162	0.000837	CcSEcCtD
Raloxifene—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000162	0.000837	CcSEcCtD
Raloxifene—CYP2C8—liver—type 2 diabetes mellitus	0.000162	0.0141	CbGeAlD
Raloxifene—Infection—Irbesartan—type 2 diabetes mellitus	0.000161	0.00083	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000161	0.00083	CcSEcCtD
Raloxifene—Shock—Irbesartan—type 2 diabetes mellitus	0.000159	0.000822	CcSEcCtD
Raloxifene—Pain—Orlistat—type 2 diabetes mellitus	0.000159	0.000822	CcSEcCtD
Raloxifene—Myalgia—Losartan—type 2 diabetes mellitus	0.000159	0.00082	CcSEcCtD
Raloxifene—Chest pain—Losartan—type 2 diabetes mellitus	0.000159	0.00082	CcSEcCtD
Raloxifene—Arthralgia—Losartan—type 2 diabetes mellitus	0.000159	0.00082	CcSEcCtD
Raloxifene—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000159	0.00082	CcSEcCtD
Raloxifene—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000159	0.00082	CcSEcCtD
Raloxifene—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000158	0.000818	CcSEcCtD
Raloxifene—Rash—Bromocriptine—type 2 diabetes mellitus	0.000157	0.000813	CcSEcCtD
Raloxifene—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000157	0.000812	CcSEcCtD
Raloxifene—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000157	0.000812	CcSEcCtD
Raloxifene—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000156	0.000808	CcSEcCtD
Raloxifene—Headache—Bromocriptine—type 2 diabetes mellitus	0.000156	0.000808	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000156	0.000807	CcSEcCtD
Raloxifene—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000156	0.000807	CcSEcCtD
Raloxifene—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000154	0.000795	CcSEcCtD
Raloxifene—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000154	0.000794	CcSEcCtD
Raloxifene—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000152	0.000786	CcSEcCtD
Raloxifene—Infection—Losartan—type 2 diabetes mellitus	0.000151	0.000781	CcSEcCtD
Raloxifene—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000151	0.00078	CcSEcCtD
Raloxifene—Shock—Losartan—type 2 diabetes mellitus	0.00015	0.000774	CcSEcCtD
Raloxifene—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000149	0.000771	CcSEcCtD
Raloxifene—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000149	0.00077	CcSEcCtD
Raloxifene—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000149	0.000769	CcSEcCtD
Raloxifene—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000148	0.000766	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000148	0.000765	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000147	0.000761	CcSEcCtD
Raloxifene—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000147	0.00076	CcSEcCtD
Raloxifene—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000147	0.00076	CcSEcCtD
Raloxifene—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000147	0.00076	CcSEcCtD
Raloxifene—Vomiting—Glyburide—type 2 diabetes mellitus	0.000145	0.00075	CcSEcCtD
Raloxifene—CYP2B6—liver—type 2 diabetes mellitus	0.000145	0.0127	CbGeAlD
Raloxifene—Rash—Glyburide—type 2 diabetes mellitus	0.000144	0.000743	CcSEcCtD
Raloxifene—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000144	0.000743	CcSEcCtD
Raloxifene—Vertigo—Ramipril—type 2 diabetes mellitus	0.000144	0.000742	CcSEcCtD
Raloxifene—Syncope—Ramipril—type 2 diabetes mellitus	0.000143	0.000741	CcSEcCtD
Raloxifene—Headache—Glyburide—type 2 diabetes mellitus	0.000143	0.000739	CcSEcCtD
Raloxifene—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000142	0.000736	CcSEcCtD
Raloxifene—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000141	0.000726	CcSEcCtD
Raloxifene—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00014	0.000724	CcSEcCtD
Raloxifene—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00014	0.000724	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00014	0.000722	CcSEcCtD
Raloxifene—Cough—Ramipril—type 2 diabetes mellitus	0.00014	0.000721	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000139	0.000717	CcSEcCtD
Raloxifene—Pain—Irbesartan—type 2 diabetes mellitus	0.000138	0.000715	CcSEcCtD
Raloxifene—Insomnia—Losartan—type 2 diabetes mellitus	0.000138	0.000711	CcSEcCtD
Raloxifene—Myalgia—Ramipril—type 2 diabetes mellitus	0.000136	0.000704	CcSEcCtD
Raloxifene—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000136	0.000704	CcSEcCtD
Raloxifene—Chest pain—Ramipril—type 2 diabetes mellitus	0.000136	0.000704	CcSEcCtD
Raloxifene—Nausea—Glyburide—type 2 diabetes mellitus	0.000136	0.0007	CcSEcCtD
Raloxifene—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000136	0.0007	CcSEcCtD
Raloxifene—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000135	0.0007	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000135	0.000699	CcSEcCtD
Raloxifene—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000134	0.000692	CcSEcCtD
Raloxifene—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000132	0.000683	CcSEcCtD
Raloxifene—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00013	0.000673	CcSEcCtD
Raloxifene—Pain—Losartan—type 2 diabetes mellitus	0.00013	0.000673	CcSEcCtD
Raloxifene—Rash—Gliclazide—type 2 diabetes mellitus	0.000129	0.000667	CcSEcCtD
Raloxifene—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000129	0.000667	CcSEcCtD
Raloxifene—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000129	0.000665	CcSEcCtD
Raloxifene—Shock—Ramipril—type 2 diabetes mellitus	0.000128	0.000664	CcSEcCtD
Raloxifene—Headache—Gliclazide—type 2 diabetes mellitus	0.000128	0.000663	CcSEcCtD
Raloxifene—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000128	0.000661	CcSEcCtD
Raloxifene—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000128	0.000661	CcSEcCtD
Raloxifene—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000128	0.000661	CcSEcCtD
Raloxifene—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000128	0.00066	CcSEcCtD
Raloxifene—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000127	0.000658	CcSEcCtD
Raloxifene—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000127	0.000655	CcSEcCtD
Raloxifene—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000126	0.000652	CcSEcCtD
Raloxifene—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000124	0.000643	CcSEcCtD
Raloxifene—Dizziness—Valsartan—type 2 diabetes mellitus	0.000124	0.000643	CcSEcCtD
Raloxifene—Dizziness—Orlistat—type 2 diabetes mellitus	0.000123	0.000635	CcSEcCtD
Raloxifene—Nausea—Gliclazide—type 2 diabetes mellitus	0.000122	0.000629	CcSEcCtD
Raloxifene—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00012	0.000622	CcSEcCtD
Raloxifene—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00012	0.000622	CcSEcCtD
Raloxifene—Vomiting—Valsartan—type 2 diabetes mellitus	0.00012	0.000618	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000119	0.000614	CcSEcCtD
Raloxifene—Rash—Valsartan—type 2 diabetes mellitus	0.000119	0.000613	CcSEcCtD
Raloxifene—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000119	0.000613	CcSEcCtD
Raloxifene—Vomiting—Orlistat—type 2 diabetes mellitus	0.000118	0.000611	CcSEcCtD
Raloxifene—Insomnia—Ramipril—type 2 diabetes mellitus	0.000118	0.00061	CcSEcCtD
Raloxifene—Headache—Valsartan—type 2 diabetes mellitus	0.000118	0.000609	CcSEcCtD
Raloxifene—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000117	0.000606	CcSEcCtD
Raloxifene—Rash—Orlistat—type 2 diabetes mellitus	0.000117	0.000606	CcSEcCtD
Raloxifene—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000117	0.000605	CcSEcCtD
Raloxifene—Headache—Orlistat—type 2 diabetes mellitus	0.000117	0.000602	CcSEcCtD
Raloxifene—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000115	0.000594	CcSEcCtD
Raloxifene—Dizziness—Metformin—type 2 diabetes mellitus	0.000113	0.000586	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000113	0.000582	CcSEcCtD
Raloxifene—Nausea—Valsartan—type 2 diabetes mellitus	0.000112	0.000578	CcSEcCtD
Raloxifene—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000111	0.000572	CcSEcCtD
Raloxifene—Nausea—Orlistat—type 2 diabetes mellitus	0.00011	0.000571	CcSEcCtD
Raloxifene—CYP3A4—liver—type 2 diabetes mellitus	0.000109	0.00955	CbGeAlD
Raloxifene—Vomiting—Metformin—type 2 diabetes mellitus	0.000109	0.000563	CcSEcCtD
Raloxifene—Rash—Metformin—type 2 diabetes mellitus	0.000108	0.000558	CcSEcCtD
Raloxifene—Dermatitis—Metformin—type 2 diabetes mellitus	0.000108	0.000558	CcSEcCtD
Raloxifene—Headache—Metformin—type 2 diabetes mellitus	0.000107	0.000555	CcSEcCtD
Raloxifene—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000107	0.000553	CcSEcCtD
Raloxifene—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000107	0.000551	CcSEcCtD
Raloxifene—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000104	0.000538	CcSEcCtD
Raloxifene—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000103	0.000533	CcSEcCtD
Raloxifene—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000103	0.000533	CcSEcCtD
Raloxifene—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000103	0.000531	CcSEcCtD
Raloxifene—Rash—Irbesartan—type 2 diabetes mellitus	0.000102	0.000527	CcSEcCtD
Raloxifene—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000102	0.000526	CcSEcCtD
Raloxifene—Nausea—Metformin—type 2 diabetes mellitus	0.000102	0.000526	CcSEcCtD
Raloxifene—Headache—Irbesartan—type 2 diabetes mellitus	0.000101	0.000524	CcSEcCtD
Raloxifene—Dizziness—Losartan—type 2 diabetes mellitus	0.000101	0.00052	CcSEcCtD
Raloxifene—Vomiting—Losartan—type 2 diabetes mellitus	9.68e-05	0.0005	CcSEcCtD
Raloxifene—Nausea—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.000496	CcSEcCtD
Raloxifene—Rash—Losartan—type 2 diabetes mellitus	9.6e-05	0.000496	CcSEcCtD
Raloxifene—Dermatitis—Losartan—type 2 diabetes mellitus	9.59e-05	0.000495	CcSEcCtD
Raloxifene—Headache—Losartan—type 2 diabetes mellitus	9.54e-05	0.000493	CcSEcCtD
Raloxifene—Nausea—Losartan—type 2 diabetes mellitus	9.04e-05	0.000467	CcSEcCtD
Raloxifene—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.93e-05	0.000461	CcSEcCtD
Raloxifene—Dizziness—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000446	CcSEcCtD
Raloxifene—Vomiting—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000429	CcSEcCtD
Raloxifene—Rash—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000425	CcSEcCtD
Raloxifene—Dermatitis—Ramipril—type 2 diabetes mellitus	8.22e-05	0.000425	CcSEcCtD
Raloxifene—Headache—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000423	CcSEcCtD
Raloxifene—Nausea—Ramipril—type 2 diabetes mellitus	7.75e-05	0.000401	CcSEcCtD
Raloxifene—HTR6—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.85e-06	7.25e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.85e-06	7.24e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AGT—type 2 diabetes mellitus	7.84e-06	7.24e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	7.83e-06	7.23e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PPARG—type 2 diabetes mellitus	7.83e-06	7.22e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	7.81e-06	7.2e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.75e-06	7.15e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP3A4—type 2 diabetes mellitus	7.75e-06	7.15e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.73e-06	7.13e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	7.72e-06	7.12e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.71e-06	7.12e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.71e-06	7.11e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APOE—type 2 diabetes mellitus	7.69e-06	7.09e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LEP—type 2 diabetes mellitus	7.69e-06	7.09e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.66e-06	7.06e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GCG—type 2 diabetes mellitus	7.62e-06	7.03e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—SLC2A4—type 2 diabetes mellitus	7.62e-06	7.03e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.6e-06	7.01e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	7.55e-06	6.97e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.55e-06	6.97e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—C3—type 2 diabetes mellitus	7.54e-06	6.95e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.52e-06	6.94e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.49e-06	6.91e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.46e-06	6.89e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	7.44e-06	6.87e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	7.44e-06	6.87e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	7.44e-06	6.87e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.4e-06	6.82e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.4e-06	6.82e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.4e-06	6.82e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	7.31e-06	6.74e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	7.3e-06	6.74e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.27e-06	6.71e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.25e-06	6.69e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	7.24e-06	6.68e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.19e-06	6.63e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.19e-06	6.63e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.17e-06	6.61e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AGT—type 2 diabetes mellitus	7.16e-06	6.61e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.14e-06	6.59e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.09e-06	6.54e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.09e-06	6.54e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	7.08e-06	6.54e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	7.05e-06	6.51e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.04e-06	6.5e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LEP—type 2 diabetes mellitus	7.02e-06	6.47e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APOE—type 2 diabetes mellitus	7.02e-06	6.47e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.97e-06	6.43e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.93e-06	6.4e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.86e-06	6.33e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.83e-06	6.3e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.83e-06	6.3e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.83e-06	6.3e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	6.81e-06	6.28e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	6.8e-06	6.27e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	6.73e-06	6.21e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	6.73e-06	6.21e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—type 2 diabetes mellitus	6.73e-06	6.21e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.71e-06	6.19e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	6.67e-06	6.15e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.62e-06	6.1e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.59e-06	6.08e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.59e-06	6.08e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.59e-06	6.08e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	6.57e-06	6.06e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.57e-06	6.06e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—INS—type 2 diabetes mellitus	6.57e-06	6.06e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	6.56e-06	6.06e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.54e-06	6.03e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	6.54e-06	6.03e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.53e-06	6.02e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.46e-06	5.96e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	6.45e-06	5.95e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	6.45e-06	5.95e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	6.45e-06	5.95e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.42e-06	5.93e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.35e-06	5.86e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.35e-06	5.85e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.32e-06	5.83e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	6.28e-06	5.79e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	6.26e-06	5.78e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.26e-06	5.77e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—AKT1—type 2 diabetes mellitus	6.21e-06	5.73e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.2e-06	5.72e-05	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—AKT1—type 2 diabetes mellitus	6.14e-06	5.66e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	6.11e-06	5.64e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	6.09e-06	5.62e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.03e-06	5.56e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—INS—type 2 diabetes mellitus	5.99e-06	5.53e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.99e-06	5.52e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	5.98e-06	5.52e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.97e-06	5.51e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.96e-06	5.5e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.9e-06	5.44e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.86e-06	5.41e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	5.86e-06	5.4e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	5.85e-06	5.4e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.85e-06	5.4e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.84e-06	5.39e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.84e-06	5.39e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	5.84e-06	5.38e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.8e-06	5.36e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.8e-06	5.35e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.79e-06	5.34e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.78e-06	5.33e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.77e-06	5.32e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.76e-06	5.31e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.76e-06	5.31e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	5.68e-06	5.24e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.61e-06	5.18e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.61e-06	5.17e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.61e-06	5.17e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.61e-06	5.17e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.61e-06	5.17e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	5.56e-06	5.13e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.56e-06	5.13e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	5.54e-06	5.11e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.51e-06	5.08e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.5e-06	5.08e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	5.46e-06	5.04e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RELA—type 2 diabetes mellitus	5.42e-06	5e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	5.39e-06	4.97e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.37e-06	4.96e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	5.35e-06	4.94e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	5.3e-06	4.89e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	5.28e-06	4.87e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.26e-06	4.85e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.26e-06	4.85e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.21e-06	4.81e-05	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AKT1—type 2 diabetes mellitus	5.2e-06	4.8e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	5.16e-06	4.76e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	5.12e-06	4.72e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	5.06e-06	4.67e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	5.03e-06	4.64e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	5.01e-06	4.63e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5e-06	4.61e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	4.99e-06	4.61e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.96e-06	4.57e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.96e-06	4.57e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.95e-06	4.56e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4.94e-06	4.56e-05	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.93e-06	4.55e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.91e-06	4.53e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.89e-06	4.51e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.86e-06	4.48e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.83e-06	4.46e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.83e-06	4.45e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4.81e-06	4.44e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.75e-06	4.38e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.66e-06	4.3e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.62e-06	4.26e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.59e-06	4.23e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.57e-06	4.22e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.57e-06	4.22e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.57e-06	4.22e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	4.56e-06	4.21e-05	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.5e-06	4.15e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.48e-06	4.13e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.48e-06	4.13e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	4.47e-06	4.13e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.46e-06	4.12e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.45e-06	4.11e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.45e-06	4.11e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.45e-06	4.11e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.43e-06	4.09e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.43e-06	4.08e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.38e-06	4.04e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.38e-06	4.04e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	4.37e-06	4.03e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.35e-06	4.01e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	4.33e-06	4e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.3e-06	3.96e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	4.28e-06	3.95e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	4.26e-06	3.93e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SRC—type 2 diabetes mellitus	4.26e-06	3.93e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	4.24e-06	3.92e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.22e-06	3.89e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	4.2e-06	3.87e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.17e-06	3.85e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.15e-06	3.83e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.12e-06	3.8e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.09e-06	3.77e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.99e-06	3.69e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.99e-06	3.69e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.99e-06	3.69e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.93e-06	3.62e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.92e-06	3.62e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.89e-06	3.59e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.89e-06	3.59e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.81e-06	3.51e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.8e-06	3.51e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.79e-06	3.49e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.76e-06	3.47e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.76e-06	3.47e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.73e-06	3.44e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.72e-06	3.43e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.7e-06	3.41e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.65e-06	3.37e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.63e-06	3.35e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.61e-06	3.33e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.61e-06	3.33e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.51e-06	3.24e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.48e-06	3.21e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.48e-06	3.21e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.46e-06	3.2e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.46e-06	3.2e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	3.44e-06	3.17e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.41e-06	3.14e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	3.32e-06	3.07e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.24e-06	2.99e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	3.18e-06	2.93e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	3.18e-06	2.93e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.15e-06	2.91e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	3.1e-06	2.86e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.99e-06	2.75e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.99e-06	2.75e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.97e-06	2.74e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.93e-06	2.71e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.91e-06	2.68e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.89e-06	2.67e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	2.87e-06	2.65e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.85e-06	2.63e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.84e-06	2.62e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.77e-06	2.55e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.72e-06	2.51e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	2.69e-06	2.48e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.66e-06	2.45e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.65e-06	2.45e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.65e-06	2.44e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.62e-06	2.42e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.58e-06	2.38e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.55e-06	2.35e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.45e-06	2.26e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.42e-06	2.23e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.4e-06	2.21e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.33e-06	2.15e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.29e-06	2.11e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.28e-06	2.1e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.25e-06	2.08e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.18e-06	2.01e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.01e-06	1.86e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.98e-06	1.83e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.95e-06	1.8e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.78e-06	1.65e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.73e-06	1.59e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.71e-06	1.57e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.71e-06	1.57e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-06	1.44e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-06	1.35e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.85e-07	7.24e-06	CbGpPWpGaD
